AXGN logo

AxoGen (AXGN) EBITDA

annual EBITDA:

$6.08M+$19.41M(+145.61%)
December 31, 2024

Summary

  • As of today (May 29, 2025), AXGN annual EBITDA is $6.08 million, with the most recent change of +$19.41 million (+145.61%) on December 31, 2024.
  • During the last 3 years, AXGN annual EBITDA has risen by +$26.97 million (+129.10%).
  • AXGN annual EBITDA is now -61.96% below its all-time high of $15.98 million, reached on December 31, 2009.

Performance

AXGN EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAXGNincome statement metrics

quarterly EBITDA:

$298.00K-$3.87M(-92.85%)
March 31, 2025

Summary

  • As of today (May 29, 2025), AXGN quarterly EBITDA is $298.00 thousand, with the most recent change of -$3.87 million (-92.85%) on March 31, 2025.
  • Over the past year, AXGN quarterly EBITDA has increased by +$2.71 million (+112.35%).
  • AXGN quarterly EBITDA is now -98.15% below its all-time high of $16.09 million, reached on December 31, 2009.

Performance

AXGN quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAXGNincome statement metrics

TTM EBITDA:

$8.79M+$2.71M(+44.59%)
March 31, 2025

Summary

  • As of today (May 29, 2025), AXGN TTM EBITDA is $8.79 million, with the most recent change of +$2.71 million (+44.59%) on March 31, 2025.
  • Over the past year, AXGN TTM EBITDA has increased by +$18.71 million (+188.53%).
  • AXGN TTM EBITDA is now -45.00% below its all-time high of $15.98 million, reached on December 31, 2009.

Performance

AXGN TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAXGNincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

AXGN EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+145.6%+112.3%+188.5%
3 y3 years+129.1%+103.0%+133.9%
5 y5 years+123.2%+104.1%+135.5%

AXGN EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+125.9%-92.8%+103.0%at high+133.8%
5 y5-yearat high+123.2%-92.8%+103.0%at high+133.8%
alltimeall time-62.0%+123.2%-98.2%+103.0%-45.0%+133.5%

AXGN EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
$298.00K(-92.8%)
$8.79M(+44.6%)
Dec 2024
$6.08M(-145.6%)
$4.17M(+108.3%)
$6.08M(+254.4%)
Sep 2024
-
$2.00M(-13.9%)
$1.72M(-180.2%)
Jun 2024
-
$2.32M(-196.4%)
-$2.14M(-78.5%)
Mar 2024
-
-$2.41M(+1124.4%)
-$9.93M(-25.5%)
Dec 2023
-$13.33M(-43.2%)
-$197.00K(-89.4%)
-$13.33M(-23.5%)
Sep 2023
-
-$1.85M(-66.1%)
-$17.42M(-6.1%)
Jun 2023
-
-$5.46M(-6.0%)
-$18.55M(-4.2%)
Mar 2023
-
-$5.81M(+35.7%)
-$19.36M(-17.5%)
Dec 2022
-$23.47M(+12.4%)
-$4.29M(+43.6%)
-$23.47M(+0.2%)
Sep 2022
-
-$2.98M(-52.5%)
-$23.43M(-9.9%)
Jun 2022
-
-$6.28M(-36.7%)
-$26.00M(+0.4%)
Mar 2022
-
-$9.92M(+133.9%)
-$25.91M(+24.1%)
Dec 2021
-$20.89M(+8.4%)
-$4.24M(-23.7%)
-$20.89M(-0.5%)
Sep 2021
-
-$5.56M(-10.2%)
-$20.99M(+34.4%)
Jun 2021
-
-$6.19M(+26.4%)
-$15.62M(-7.2%)
Mar 2021
-
-$4.90M(+12.8%)
-$16.82M(-12.7%)
Dec 2020
-$19.27M(-26.5%)
-$4.34M(+2209.0%)
-$19.27M(-8.9%)
Sep 2020
-
-$188.00K(-97.5%)
-$21.16M(-18.1%)
Jun 2020
-
-$7.39M(+0.6%)
-$25.85M(+4.4%)
Mar 2020
-
-$7.35M(+18.0%)
-$24.75M(-5.6%)
Dec 2019
-$26.22M(+28.9%)
-$6.22M(+27.6%)
-$26.22M(+4.9%)
Sep 2019
-
-$4.88M(-22.6%)
-$25.00M(+4.1%)
Jun 2019
-
-$6.30M(-28.5%)
-$24.01M(-1.4%)
Mar 2019
-
-$8.82M(+76.0%)
-$24.36M(+19.8%)
Dec 2018
-$20.34M(+174.3%)
-$5.01M(+29.0%)
-$20.33M(+19.8%)
Sep 2018
-
-$3.88M(-41.6%)
-$16.98M(+17.5%)
Jun 2018
-
-$6.65M(+38.7%)
-$14.44M(+58.2%)
Mar 2018
-
-$4.79M(+190.0%)
-$9.13M(+23.1%)
Dec 2017
-$7.42M(-3.9%)
-$1.65M(+22.2%)
-$7.42M(-11.2%)
Sep 2017
-
-$1.35M(+1.5%)
-$8.35M(+3.5%)
Jun 2017
-
-$1.33M(-56.7%)
-$8.07M(-2.1%)
Mar 2017
-
-$3.08M(+18.8%)
-$8.24M(+6.9%)
Dec 2016
-$7.71M(-14.2%)
-$2.59M(+141.5%)
-$7.71M(+0.2%)
Sep 2016
-
-$1.07M(-28.6%)
-$7.70M(-9.1%)
Jun 2016
-
-$1.50M(-41.0%)
-$8.47M(-6.4%)
Mar 2016
-
-$2.55M(-1.2%)
-$9.05M(+0.6%)
Dec 2015
-$8.99M(-6.3%)
-$2.58M(+40.2%)
-$8.99M(-0.7%)
Sep 2015
-
-$1.84M(-11.5%)
-$9.06M(+1.0%)
Jun 2015
-
-$2.08M(-16.6%)
-$8.97M(-1.9%)
Mar 2015
-
-$2.49M(-5.8%)
-$9.14M(-4.8%)
Dec 2014
-$9.60M(+1.9%)
-$2.65M(+51.5%)
-$9.60M(-0.9%)
Sep 2014
-
-$1.75M(-22.4%)
-$9.68M(-4.9%)
Jun 2014
-
-$2.25M(-23.7%)
-$10.18M(+0.9%)
Mar 2014
-
-$2.95M(+8.2%)
-$10.08M(+7.1%)
Dec 2013
-$9.42M(+26.2%)
-$2.73M(+21.6%)
-$9.42M(+5.8%)
Sep 2013
-
-$2.24M(+4.0%)
-$8.91M(+5.2%)
Jun 2013
-
-$2.16M(-5.7%)
-$8.47M(+8.4%)
Mar 2013
-
-$2.29M(+3.2%)
-$7.81M(+5.7%)
Dec 2012
-$7.46M(+13.8%)
-$2.22M(+22.7%)
-$7.39M(+4.7%)
Sep 2012
-
-$1.81M(+20.4%)
-$7.06M(-9.5%)
Jun 2012
-
-$1.50M(-19.5%)
-$7.79M(+4.2%)
Mar 2012
-
-$1.86M(-1.1%)
-$7.48M(+14.0%)
Dec 2011
-$6.56M(+58.9%)
-$1.88M(-25.9%)
-$6.56M(-7.3%)
Sep 2011
-
-$2.54M(+114.2%)
-$7.08M(+41.0%)
Jun 2011
-
-$1.19M(+25.9%)
-$5.02M(+20.5%)
Mar 2011
-
-$943.50K(-60.7%)
-$4.16M(+16.0%)
Dec 2010
-$4.13M(-125.8%)
-$2.40M(+395.4%)
-$3.59M(-124.1%)
Sep 2010
-
-$484.90K(+45.7%)
$14.90M(-2.4%)
Jun 2010
-
-$332.90K(-10.0%)
$15.26M(-3.0%)
Mar 2010
-
-$369.70K(-102.3%)
$15.74M(-1.5%)
Dec 2009
$15.98M(-1645.8%)
$16.09M(<-9900.0%)
$15.98M(-7185.9%)
Sep 2009
-
-$126.00K(-186.7%)
-$225.50K(-66.8%)
Jun 2009
-
$145.30K(-213.0%)
-$679.50K(-32.1%)
Mar 2009
-
-$128.60K(+10.7%)
-$1.00M(-3.2%)
Dec 2008
-$1.03M(+32.9%)
-$116.20K(-80.0%)
-$1.03M(+9.7%)
Sep 2008
-
-$580.00K(+230.5%)
-$942.20K(+14.1%)
Jun 2008
-
-$175.50K(+8.4%)
-$825.90K(+1.2%)
Mar 2008
-
-$161.90K(+552.8%)
-$816.20K(+5.0%)
Dec 2007
-$777.60K(+109.1%)
-$24.80K(-94.7%)
-$777.60K(-11.5%)
Sep 2007
-
-$463.70K(+179.7%)
-$878.80K(+80.2%)
Jun 2007
-
-$165.80K(+34.5%)
-$487.60K(+11.1%)
Mar 2007
-
-$123.30K(-2.1%)
-$438.90K(+18.0%)
Dec 2006
-$371.90K(+21.3%)
-$126.00K(+73.8%)
-$371.90K(+266.8%)
Sep 2006
-
-$72.50K(-38.1%)
-$101.40K(+131.0%)
Jun 2006
-
-$117.10K(+108.0%)
-$43.90K(-495.5%)
Mar 2006
-
-$56.30K(-139.0%)
$11.10K(-103.6%)
DateAnnualQuarterlyTTM
Dec 2005
-$306.50K(+213.7%)
$144.50K(-1063.3%)
-$306.50K(-58.2%)
Sep 2005
-
-$15.00K(-75.8%)
-$732.70K(-1420.2%)
Jun 2005
-
-$62.10K(-83.4%)
$55.50K(-333.2%)
Mar 2005
-
-$373.90K(+32.7%)
-$23.80K(-129.3%)
Dec 2004
-$97.70K(-91.1%)
-$281.70K(-136.4%)
$81.20K(-109.6%)
Sep 2004
-
$773.20K(-646.8%)
-$844.00K(-46.1%)
Jun 2004
-
-$141.40K(-47.4%)
-$1.57M(-8.9%)
Mar 2004
-
-$268.90K(-77.7%)
-$1.72M(+7.3%)
Dec 2003
-$1.09M(-41.5%)
-$1.21M(-2457.2%)
-$1.60M(+79.6%)
Sep 2003
-
$51.20K(-117.4%)
-$891.90K(-21.4%)
Jun 2003
-
-$294.10K(+93.0%)
-$1.14M(-19.4%)
Mar 2003
-
-$152.40K(-69.3%)
-$1.41M(-24.6%)
Dec 2002
-$1.87M(-17.6%)
-$496.60K(+158.5%)
-$1.87M(+36.2%)
Sep 2002
-
-$192.10K(-66.1%)
-$1.37M(-15.1%)
Jun 2002
-
-$567.00K(-7.2%)
-$1.61M(-40.6%)
Mar 2002
-
-$611.00K(+40.0%)
-$2.72M(-16.2%)
Dec 2001
-$2.26M(-9.1%)
-
-
Sep 2001
-
-$436.30K(-73.9%)
-$3.24M(+1.2%)
Jun 2001
-$2.49M(+25.6%)
-$1.67M(+1127.0%)
-$3.21M(+48.3%)
Mar 2001
-
-$136.30K(-86.4%)
-$2.16M(-12.0%)
Dec 2000
-
-$999.30K(+150.8%)
-$2.46M(+25.5%)
Sep 2000
-
-$398.50K(-36.6%)
-$1.96M(-4.9%)
Jun 2000
-$1.98M(+120.3%)
-$628.40K(+46.2%)
-$2.06M(+26.3%)
Mar 2000
-
-$429.90K(-14.0%)
-$1.63M(+16.4%)
Dec 1999
-
-$500.00K(0.0%)
-$1.40M(+7.7%)
Sep 1999
-
-$500.00K(+150.0%)
-$1.30M(+62.5%)
Jun 1999
-$900.00K(-325.0%)
-$200.00K(0.0%)
-$800.00K(+33.3%)
Mar 1999
-
-$200.00K(-50.0%)
-$600.00K(+20.0%)
Dec 1998
-
-$400.00K(<-9900.0%)
-$500.00K(<-9900.0%)
Sep 1998
-
$0.00(0.0%)
$0.00(-100.0%)
Jun 1998
$400.00K(-63.6%)
$0.00(-100.0%)
$400.00K(-50.0%)
Mar 1998
-
-$100.00K(-200.0%)
$800.00K(-33.3%)
Dec 1997
-
$100.00K(-75.0%)
$1.20M(+9.1%)
Sep 1997
-
$400.00K(0.0%)
$1.10M(+10.0%)
Jun 1997
$1.10M(+120.0%)
$400.00K(+33.3%)
$1.00M(+11.1%)
Mar 1997
-
$300.00K(>+9900.0%)
$900.00K(-18.2%)
Dec 1996
-
$0.00(-100.0%)
$1.10M(+83.3%)
Sep 1996
-
$300.00K(0.0%)
$600.00K(0.0%)
Jun 1996
$500.00K(-44.4%)
$300.00K(-40.0%)
$600.00K(+200.0%)
Mar 1996
-
$500.00K(-200.0%)
$200.00K(0.0%)
Dec 1995
-
-$500.00K(-266.7%)
$200.00K(-77.8%)
Sep 1995
-
$300.00K(-400.0%)
$900.00K(+12.5%)
Jun 1995
$900.00K(-35.7%)
-$100.00K(-120.0%)
$800.00K(-27.3%)
Mar 1995
-
$500.00K(+150.0%)
$1.10M(+22.2%)
Dec 1994
-
$200.00K(0.0%)
$900.00K(-10.0%)
Sep 1994
-
$200.00K(0.0%)
$1.00M(-28.6%)
Jun 1994
$1.40M(+16.7%)
$200.00K(-33.3%)
$1.40M(-12.5%)
Mar 1994
-
$300.00K(0.0%)
$1.60M(0.0%)
Dec 1993
-
$300.00K(-50.0%)
$1.60M(+14.3%)
Sep 1993
-
$600.00K(+50.0%)
$1.40M(+16.7%)
Jun 1993
$1.20M(-20.0%)
$400.00K(+33.3%)
$1.20M(+9.1%)
Mar 1993
-
$300.00K(+200.0%)
$1.10M(-8.3%)
Dec 1992
-
$100.00K(-75.0%)
$1.20M(-20.0%)
Sep 1992
-
$400.00K(+33.3%)
$1.50M(0.0%)
Jun 1992
$1.50M(+7.1%)
$300.00K(-25.0%)
$1.50M(-6.3%)
Mar 1992
-
$400.00K(0.0%)
$1.60M(+14.3%)
Dec 1991
-
$400.00K(0.0%)
$1.40M(+7.7%)
Sep 1991
-
$400.00K(0.0%)
$1.30M(0.0%)
Jun 1991
$1.40M(+55.6%)
$400.00K(+100.0%)
$1.30M(-165.0%)
Mar 1991
-
$200.00K(-33.3%)
-$2.00M(<-9900.0%)
Dec 1990
-
$300.00K(-25.0%)
$0.00(-100.0%)
Sep 1990
-
$400.00K(-113.8%)
$1.20M(+9.1%)
Jun 1990
$900.00K(-10.0%)
-$2.90M(-231.8%)
$1.10M(-1200.0%)
Mar 1990
-
$2.20M(+46.7%)
-$100.00K(-85.7%)
Dec 1989
-
$1.50M(+400.0%)
-$700.00K(+40.0%)
Sep 1989
-
$300.00K(-107.3%)
-$500.00K(-171.4%)
Jun 1989
$1.00M(-23.1%)
-$4.10M(-356.3%)
$700.00K(-56.3%)
Mar 1989
-
$1.60M(-5.9%)
$1.60M(+14.3%)
Dec 1988
-
$1.70M(+13.3%)
$1.40M(+27.3%)
Sep 1988
-
$1.50M(-146.9%)
$1.10M(+10.0%)
Jun 1988
$1.30M(+85.7%)
-$3.20M(-328.6%)
$1.00M(-9.1%)
Mar 1988
-
$1.40M(0.0%)
$1.10M(+22.2%)
Dec 1987
-
$1.40M(0.0%)
$900.00K(+28.6%)
Sep 1987
-
$1.40M(-145.2%)
$700.00K(+40.0%)
Jun 1987
$700.00K
-$3.10M(-358.3%)
$500.00K(-86.1%)
Mar 1987
-
$1.20M(0.0%)
$3.60M(+50.0%)
Dec 1986
-
$1.20M(0.0%)
$2.40M(+100.0%)
Sep 1986
-
$1.20M
$1.20M

FAQ

  • What is AxoGen annual EBITDA?
  • What is the all time high annual EBITDA for AxoGen?
  • What is AxoGen annual EBITDA year-on-year change?
  • What is AxoGen quarterly EBITDA?
  • What is the all time high quarterly EBITDA for AxoGen?
  • What is AxoGen quarterly EBITDA year-on-year change?
  • What is AxoGen TTM EBITDA?
  • What is the all time high TTM EBITDA for AxoGen?
  • What is AxoGen TTM EBITDA year-on-year change?

What is AxoGen annual EBITDA?

The current annual EBITDA of AXGN is $6.08M

What is the all time high annual EBITDA for AxoGen?

AxoGen all-time high annual EBITDA is $15.98M

What is AxoGen annual EBITDA year-on-year change?

Over the past year, AXGN annual EBITDA has changed by +$19.41M (+145.61%)

What is AxoGen quarterly EBITDA?

The current quarterly EBITDA of AXGN is $298.00K

What is the all time high quarterly EBITDA for AxoGen?

AxoGen all-time high quarterly EBITDA is $16.09M

What is AxoGen quarterly EBITDA year-on-year change?

Over the past year, AXGN quarterly EBITDA has changed by +$2.71M (+112.35%)

What is AxoGen TTM EBITDA?

The current TTM EBITDA of AXGN is $8.79M

What is the all time high TTM EBITDA for AxoGen?

AxoGen all-time high TTM EBITDA is $15.98M

What is AxoGen TTM EBITDA year-on-year change?

Over the past year, AXGN TTM EBITDA has changed by +$18.71M (+188.53%)
On this page